https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002023-02-13 / Cancers (Basel) 2023 Feb;15(4)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2023-02-13 / Cancers (Basel) 2023 Feb;15(4)2023-02-13 00:00:002023-05-30 16:20:40Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
https://www.iozk.de/wp-content/uploads/2020/11/IOZK_team_van-gool_175828-ret.jpg518690IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2023-01-23 16:08:352023-01-25 16:42:45Stefaan van Gool ist Herausgeber einer Sonderausgabe im Journal of Molecular Sciences
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2023-01-20 16:48:372023-01-25 16:59:59Hyperthermie die vierte Säule in der Onkologie - Trailer zum Film
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002022-10-27 / Int J Mol Sci 2022 Oct;23(21)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2022-10-27 / Int J Mol Sci 2022 Oct;23(21)2022-10-27 00:00:002023-01-31 13:01:45Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002022-02-28 / Biomedicines 2022 Feb;10(3)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2022-02-28 / Biomedicines 2022 Feb;10(3)2022-06-02 00:00:002022-06-27 12:27:29Poster presentation at the International Symposium on Pediatric Neuro-Oncology
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002022-02-28 / Biomedicines 2022 Feb;10(3)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2022-02-28 / Biomedicines 2022 Feb;10(3)2022-06-02 00:00:002022-06-27 12:26:23Poster presentation at the annual meeting of the Association for Cancer Immunotherapy
https://www.iozk.de/wp-content/uploads/2021/10/PrimoMedico.jpg4541400IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2021-10-13 14:19:262021-10-13 14:39:09Primo Medico Fachärzte Talk: Dr. Stücker im Interview
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-07-04 / Cancer Immunol Immunother 2021 Jul;https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-07-04 / Cancer Immunol Immunother 2021 Jul;2021-07-04 00:00:002021-11-15 12:29:15Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors
Neue IOZK Veröffentlichung zum Thema Liquid Biopsy
/in IOZK Aktuelles, IOZK Veröffentlichungen /von IOZKIndividualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2023-02-13 / Cancers (Basel) 2023 Feb;15(4)Stefaan van Gool ist Herausgeber einer Sonderausgabe im Journal of Molecular Sciences
/in Brain Tumors in Children, IOZK Aktuelles, IOZK Veröffentlichungen /von IOZKHyperthermie die vierte Säule in der Onkologie – Trailer zum Film
/in Externe Meldungen, IOZK Aktuelles /von IOZKCounteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
/in International Publications, IOZK Veröffentlichungen /von 2022-10-27 / Int J Mol Sci 2022 Oct;23(21)Poster presentation at the International Symposium on Pediatric Neuro-Oncology
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2022-02-28 / Biomedicines 2022 Feb;10(3)Poster presentation at the annual meeting of the Association for Cancer Immunotherapy
/in Glioblastoma, International Publications, IOZK bei Fachtagungen, IOZK Veröffentlichungen /von 2022-02-28 / Biomedicines 2022 Feb;10(3)Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2022-02-16 / Genes Immun 2022 Feb;Primo Medico Fachärzte Talk: Dr. Stücker im Interview
/in IOZK In der Presse /von IOZKStem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors
/in International Publications, IOZK Veröffentlichungen /von 2021-07-04 / Cancer Immunol Immunother 2021 Jul;